About this trial
To compare clinical and molecular effects of nutritional support (immunonutrition or EPA-DHA enriched oral nutritional supplements) in patients with cancer undergoing surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with cancer undergoing surgery (primary tumor location; gastrointestinal tract, ovarian, peritoneal carcinomatosis)
Disqualifiers
End-stage liver disease
End-stage kidney disease
Trial population
Patients with cancer undergoing surgery (primary tumor location; gastrointestinal tract, ovarian, peritoneal carcinomatosis
Trial design
Cohort
Prospective
Treatments tested in this trial
Immunonutrition
Dietary supplementPatients will receive nutritional advice and 2 oral nutritional supplements with arginine, fatty acids and nucleotides
EPA-DHA
Dietary supplementPatients will receive nutritional advice and 2 oral nutritional supplements enriched with EPA and DHA
Treatment groups
Trial outcomes
Primary outcomes
Body composition changes
changes in fat mass, fat-free mass, lean mass and phase angle
Secondary outcomes
Cytokines changes
Changes in circulating cytokines (IL6, IL8, MIP10)
Metabolites changes
Changes in circulating metabolites including lipids and muscle-related metabolites
Sponsors and contacts
Click on the lead sponsor to view all of their trials.